A detailed history of Cerity Partners LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 13,769 shares of MRNA stock, worth $507,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,769
Previous 12,869 6.99%
Holding current value
$507,387
Previous $1.53 Million 39.79%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $57,276 - $112,626
900 Added 6.99%
13,769 $920,000
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $216,690 - $356,712
-2,141 Reduced 14.26%
12,869 $1.53 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $801,112 - $1.08 Million
9,384 Added 166.8%
15,010 $1.6 Million
Q4 2023

Jan 26, 2024

BUY
$69.51 - $104.43 $201,787 - $303,160
2,903 Added 106.61%
5,626 $559,000
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $251,822 - $330,705
-2,612 Reduced 48.96%
2,723 $281,000
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $141,252 - $191,351
1,192 Added 28.77%
5,335 $648,000
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $427,193 - $620,415
-3,149 Reduced 43.18%
4,143 $636,000
Q4 2022

Feb 15, 2023

BUY
$118.38 - $210.04 $186,448 - $330,813
1,575 Added 27.55%
7,292 $1.31 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $67,772 - $111,459
-574 Reduced 9.12%
5,717 $676,000
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $275,489 - $415,339
2,352 Added 59.71%
6,291 $898,000
Q1 2022

Apr 25, 2022

BUY
$126.46 - $235.05 $28,959 - $53,826
229 Added 6.17%
3,939 $679,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $322,245 - $525,863
1,427 Added 62.51%
3,710 $947,000
Q3 2021

Oct 25, 2021

BUY
$221.9 - $484.47 $62,797 - $137,105
283 Added 14.15%
2,283 $879,000
Q2 2021

Aug 11, 2021

SELL
$129.91 - $234.98 $1,299 - $2,349
-10 Reduced 0.5%
2,000 $470,000
Q1 2021

Aug 11, 2021

BUY
$109.18 - $185.98 $219,451 - $373,819
2,010 New
2,010 $263,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.